Morgan Stanley’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
3,540,192
+1,124,608
| +47% | +$1.6M | ﹤0.01% | 4062 |
|
|
2025
Q1 | $3.7M | Buy |
2,415,584
+1,343,800
| +125% | +$2.06M | ﹤0.01% | 4180 |
|
|
2024
Q4 | $2.66M | Buy |
1,071,784
+591,011
| +123% | +$1.47M | ﹤0.01% | 4499 |
|
|
2024
Q3 | $553K | Buy |
480,773
+294,430
| +158% | +$339K | ﹤0.01% | 5354 |
|
|
2024
Q2 | $205K | Sell |
186,343
-305,323
| -62% | -$336K | ﹤0.01% | 5664 |
|
|
2024
Q1 | $610K | Sell |
491,666
-1,460,092
| -75% | -$1.81M | ﹤0.01% | 5218 |
|
|
2023
Q4 | $2.05M | Buy |
1,951,758
+253,367
| +15% | +$266K | ﹤0.01% | 4911 |
|
|
2023
Q3 | $11.6M | Buy |
1,698,391
+63,576
| +4% | +$435K | ﹤0.01% | 2983 |
|
|
2023
Q2 | $17M | Buy |
1,634,815
+958,197
| +142% | +$9.94M | ﹤0.01% | 2637 |
|
|
2023
Q1 | $5.47M | Buy |
676,618
+536,214
| +382% | +$4.34M | ﹤0.01% | 3711 |
|
|
2022
Q4 | $2.21M | Sell |
140,404
-27,408
| -16% | -$432K | ﹤0.01% | 4394 |
|
|
2022
Q3 | $2.64M | Buy |
167,812
+6,702
| +4% | +$105K | ﹤0.01% | 4239 |
|
|
2022
Q2 | $2.25M | Buy |
161,110
+130,171
| +421% | +$1.82M | ﹤0.01% | 4439 |
|
|
2022
Q1 | $532K | Sell |
30,939
-11,930
| -28% | -$205K | ﹤0.01% | 5368 |
|
|
2021
Q4 | $623K | Buy |
42,869
+10,397
| +32% | +$151K | ﹤0.01% | 5409 |
|
|
2021
Q3 | $585K | Buy |
32,472
+9,133
| +39% | +$165K | ﹤0.01% | 5391 |
|
|
2021
Q2 | $410K | Buy |
23,339
+14,465
| +163% | +$254K | ﹤0.01% | 5648 |
|
|
2021
Q1 | $224K | Sell |
8,874
-9,329
| -51% | -$235K | ﹤0.01% | 5594 |
|
|
2020
Q4 | $118K | Sell |
18,203
-2,056
| -10% | -$13.3K | ﹤0.01% | 5842 |
|
|
2020
Q3 | $52K | Buy |
20,259
+6,713
| +50% | +$17.2K | ﹤0.01% | 5707 |
|
|
2020
Q2 | $22K | Buy |
13,546
+9,724
| +254% | +$15.8K | ﹤0.01% | 5978 |
|
|
2020
Q1 | $3K | Sell |
3,822
-2,515,160
| -100% | -$1.97M | ﹤0.01% | 6303 |
|
|
2019
Q4 | $4.76M | Buy |
2,518,982
+790,841
| +46% | +$1.49M | ﹤0.01% | 3256 |
|
|
2019
Q3 | $1.87M | Buy |
1,728,141
+1,560,779
| +933% | +$1.69M | ﹤0.01% | 3860 |
|
|
2019
Q2 | $367K | Sell |
167,362
-39,393
| -19% | -$86.4K | ﹤0.01% | 4755 |
|
|
2019
Q1 | $1.24M | Buy |
206,755
+39,712
| +24% | +$238K | ﹤0.01% | 3966 |
|
|
2018
Q4 | $1.23M | Sell |
167,043
-216,775
| -56% | -$1.6M | ﹤0.01% | 4127 |
|
|
2018
Q3 | $5.57M | Buy |
383,818
+317,847
| +482% | +$4.62M | ﹤0.01% | 3066 |
|
|
2018
Q2 | $1.32M | Sell |
65,971
-50,607
| -43% | -$1.01M | ﹤0.01% | 4425 |
|
|
2018
Q1 | $2.04M | Sell |
116,578
-71,137
| -38% | -$1.25M | ﹤0.01% | 3997 |
|
|
2017
Q4 | $4.63M | Buy |
187,715
+154,737
| +469% | +$3.82M | ﹤0.01% | 3192 |
|
|
2017
Q3 | $851K | Buy |
32,978
+13,004
| +65% | +$336K | ﹤0.01% | 4536 |
|
|
2017
Q2 | $541K | Buy |
19,974
+444
| +2% | +$12K | ﹤0.01% | 4750 |
|
|
2017
Q1 | $583K | Sell |
19,530
-39,276
| -67% | -$1.17M | ﹤0.01% | 4745 |
|
|
2016
Q4 | $1.6M | Buy |
58,806
+31,869
| +118% | +$864K | ﹤0.01% | 4118 |
|
|
2016
Q3 | $690K | Buy |
26,937
+26,823
| +23,529% | +$687K | ﹤0.01% | 4304 |
|
|
2016
Q2 | $2K | Buy |
+114
| New | +$2K | ﹤0.01% | 6357 |
|
|
2016
Q1 | – | Sell |
-391
| Closed | -$11K | – | 6552 |
|
|
2015
Q4 | $11K | Buy |
+391
| New | +$11K | ﹤0.01% | 6206 |
|